Rchr
J-GLOBAL ID：200901053667915702
Update date: Sep. 25, 2022
Shirasaki Fumiaki
シラサキ フミアキ | Shirasaki Fumiaki
Research field (1)：
Dermatology
Research keywords (2)：
悪性黒色腫
, Dermatology
Research theme for competitive and other funds (2)：
悪性黒色腫におけるテネイシンC発現の分子機序
Molecular mechanism of Tenascin-c expression in malignant melanoma
MISC (11)：
F Shirasaki, M Takata, N Hatta, K Takehara. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. CANCER RESEARCH. 2001. 61. 20. 7422-7425
F Shirasaki, M Takata, N Hatta, K Takehara. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. CANCER RESEARCH. 2001. 61. 20. 7422-7425
Fli1 inhibits collagen type I production in dermal fibroblast via a Sp1 dependent pathway. J Biol Chem. 2001. 276. 24. 20839-48
SHIRASAKI Fumiaki, TAKATA Minoru, ISHII Takayuki, FUJIMOTO Akihide, HATTA Naohito, TAKEHARA Kazuhiko. Total Androgen Blockade Therapy for an Advanced of Extramammary Paget's carcinoma. Skin Cancer. 2001. 16. 2. 247-250
Fli1 inhibits collagen type I production in dermal fibroblast via a Sp1 dependent pathway. J Biol Chem. 2001. 276. 24. 20839-48
ｍore...
Education (4)：
- 1996 Kanazawa University
- 1996 Kanazawa University Graduate School, Division of Medicine
- 1992 Kanazawa University
- 1992 Kanazawa University Faculty of Medicine
Professional career (1)：
医学博士
Work history (1)：
Kanazawa University Hospital, Dermatology
Association Membership(s) (3)：
日本研究皮膚科学会
, 日本皮膚科学会
, 日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
